Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Metastatic Malignant Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06494514
What this trial is testing

NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Du Juan 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05170204
What this trial is testing

A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 68
Early research (Phase 1)Ended earlyNCT01134601
What this trial is testing

A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum

Who this might be right for
Non-Metastatic Adenocarcinoma of the Rectum
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)UnknownNCT06130007
What this trial is testing

A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.

Who this might be right for
Oral Squamous Cell Carcinoma
Xuekui Liu 48
Early research (Phase 1)Ended earlyNCT01334099
What this trial is testing

Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
University Health Network, Toronto 6
Testing effectiveness (Phase 2)Study completedNCT00014599
What this trial is testing

Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva

Who this might be right for
Vulvar Cancer
European Organisation for Research and Treatment of Cancer - EORTC 31
Large-scale testing (Phase 3)UnknownNCT04617821
What this trial is testing

AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma
Fudan University 300
Large-scale testing (Phase 3)Active Not RecruitingNCT02799706
What this trial is testing

Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 885
Not applicableWithdrawnNCT02341170
What this trial is testing

HS-PCI in Locally Advanced Adenocarcinoma of the Lung

Who this might be right for
Lung CancerAdenocarcinomaLymphatic Metastasis
Universitätsmedizin Mannheim
Testing effectiveness (Phase 2)UnknownNCT02123381
What this trial is testing

Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Thoracic Middle-lower Segment Esophageal Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute 100
Large-scale testing (Phase 3)Looking for participantsNCT05201430
What this trial is testing

Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Fudan University 300
Testing effectiveness (Phase 2)WithdrawnNCT00696007
What this trial is testing

Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer

Who this might be right for
Transitional Cell Carcinoma
Lahey Clinic
Early research (Phase 1)Study completedNCT02586207
What this trial is testing

Pembrolizumab in Combination With CRT for LA-SCCHN

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+4 more
Sanford Health 59
Early research (Phase 1)Study completedNCT00026364
What this trial is testing

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 22
Early research (Phase 1)Study completedNCT00471432
What this trial is testing

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Who this might be right for
Bladder CancerBreast CancerKidney Cancer+4 more
NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07450963
What this trial is testing

Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT

Who this might be right for
Locally Advanced Cervical Cancer
Ruijin Hospital 45
Not applicableStudy completedNCT04143230
What this trial is testing

Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool

Who this might be right for
Locally Advanced CancerMetastatic CancerChronic Respiratory Failure+3 more
A.O.U. Città della Salute e della Scienza 660
Early research (Phase 1)Study completedNCT01713036
What this trial is testing

Oral Bioavailability and Mass Balance Trial With Pimasertib

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Merck KGaA, Darmstadt, Germany 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585814
What this trial is testing

CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Microsatellite Stable Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Shanghai Changzheng Hospital 30
Early research (Phase 1)UnknownNCT04612504
What this trial is testing

SynOV1.1 Intratumoral Injection Study

Who this might be right for
Hepatocellular Carcinoma
Beijing Syngentech Co., Ltd. 15
Next Page